Get started
Author

Shubhadeep D. Sinha

Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India
2022 · Shubhadeep Sinha, Kumarasamy N, et al. · Cureus · 31
PDF
Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges
2024 · Shubhadeep D. Sinha, Sreenivasa Chary Sriramadasu, et al. · Pharmaceutical Medicine · 28
Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
2019 · Shubhadeep D. Sinha, Vamsi Krishna Bandi, et al. · BMC Nephrology · 25
PDF
Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients
2023 · Shubhadeep D. Sinha, Avula Rajamma, et al. · Clinical Drug Investigation · 9
Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study
2023 · Shubhadeep D. Sinha, Sridevi Perapogu, et al. · Journal of Asthma · 9
Darbepoetin Alfa Versus Erythropoietin Alfa for Treatment of Renal Anemia in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage: A Randomized Non-inferiority Trial.
2019 · K S Mehta, S D Sinha, et al. · PubMed · 9
Developing Biosimilars: Challenges and Opportunities
2025 · Shubhadeep Sinha, Ruby Raphael · Pharmaceutical Medicine · 7
Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial
2021 · Shubhadeep Sinha, Sreenivasa Chary, et al. · Cureus · 6
PDF
A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder
2021 · Shubhadeep Sinha, Sreenivasa Chary, et al. · Cureus · 6
PDF
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero’s adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy
2020 · Shubhadeep Sinha, Biswadip Ghosh, et al. · BMC Rheumatology · 6
PDF
Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in India.
2021 · Shubhadeep Sinha, Sreenivasa Chary, et al. · PubMed · 5
A Prospective, Randomized, Multiple-Dose, Multi-Center, Comparative Clinical Study to Evaluate the Efficacy, Safety, Immunogenicity of a biosimilar Bevacizumab (Test product, Hetero) and Reference Medicinal Product (Bevacizumab, Roche) in Patients of Metastatic Colorectal Cancer.
2018 · Suresh Advani, Ghanashyam Biswas, et al. · PubMed · 5
Polmacoxib 2mg in patients with mild to moderate idiopathic osteoarthritis of hip/knee-a randomized, double-anonymous study
2024 · Shubhadeep D. Sinha, Tadikonda Bhavani Prasad, et al. · Pain Management · 4
PDF
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India
2023 · Shubhadeep D Sinha, Ghanashyam Biswas, et al. · Cancer Informatics · 2
PDF
Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study
2021 · Shubhadeep D Sinha, Saroj K Sinha, et al. · Cureus · 2
PDF
A Randomized, Multiple-Dose, Multicenter, Comparative Parallel Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Non-Hodgkin's Lymphoma (HERILY)
2018 · Suresh Advani, Ghanashyam Biswas, et al. · Indian Journal of Medical and Paediatric Oncology · 2
PDF
Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
2021 · Shubhadeep Sinha, Vamsi Krishna Bandi, et al. · Cureus · 1
PDF
Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
2019 · Shubhadeep D. Sinha, Vamsi Krishna Bandi, et al. · BMC Nephrology · 1
PDF
Efficacy, Safety and Immunogenecitystudy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Follicular Lymphoma Preliminary report (HERILY).
2017 · Suresh Advani, Shubhadeep Sinha, et al. · PubMed · 1
Safety and tolerability of prescribed usage of Derise® (Darbepoetin Alfa, Hetero) in symptomatic anemia: A Phase IV Post-Authorization Study
2020 · Shubhadeep Sinha, Vamsi Krishna Bandi, et al.
PDF
Works count: 23
Citation count: 159
H-index: 7
I10-index: 3
Year
Topic
Type